Ahern, D., Gorkin, L., Anderson, J., Tierney, C, Hallstrom, A., Ewart, C, Capone, R.J., Schron, E., Kornfeid, D., Herd, J.A. et al. (1990). Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). American Journal of Cardiology 66, 59–62.CrossRefGoogle ScholarPubMed

Alderman, M.H. & Schoenbaum, E.E. (1975). Detection and treatment of hypertension at the worksite. New England Journal of Medicine 293, 65–68.CrossRefGoogle Scholar

Alderman, M.H., Madhavan, S., Ooi, W.L., Cohen, H., Sealey, J.E. & Laragh, J.H. (1991). Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. New England Journal of Medicine 324, 1098–1104.CrossRefGoogle ScholarPubMed

Anda, R., Williamson, D., Jones, D., Macera, C, Eaker, E., Glassman, A. & Marks, J. (1993). Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 4, 285–294.CrossRefGoogle Scholar

Aromaa, A., Raitasalo, R., Reunanen, A., Impivaara, O., Heliovaara, M., Knekt, P., Lehtinen, V.Joukamaa, M. & Maatela, J. (1994). Depression and cardiovascular diseases. Ada Psychiatrica Scandinavica, Supplementum No. 377, 77–82.CrossRefGoogle ScholarPubMed

Barefoot, J.C. & Schroll, M. (1996). Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93, 1976–1980.CrossRefGoogle Scholar

Berkman, L.F. & Jaffe, A.S., for the ENRICHD Investigators (2001) The effects of treating depression and low social support on clinical events after a myocardial infarction (Abstract). Circulation 2001 104(25), IB.Google Scholar

Bingefors, K., Isacson, D., Von Knorring, L., Smedby, B. &Wicknertz, K. (1996). Antidepressant-treated patients in ambulatory care. Mortality during a nine-year period after first treatment. British Journal of Psychiatry 169, 647–654.CrossRefGoogle ScholarPubMed

Carney, R.M., Rich, M.W., Freedland, K.E., Saini, J., teVelde, A., Simeone, C. & Clark, K. (1988). Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosomatic Medicine 50, 627–633.CrossRefGoogle ScholarPubMed

Carney, R.M., Saunders, R.D., Freedland, K.E., Stein, P., Rich, M.W. & Jaffe, A.S. (1995a). Association of depression with reduced heart rate variability in coronary artery disease. American Journal of Cardiology 76, 562–564.CrossRefGoogle ScholarPubMed

Carney, R.M., Rich, M.W. & Jaffe, A.S. (1995b). Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Annals of Behavioral Medicine 17, 142–149.CrossRefGoogle ScholarPubMed

Cohen, H.W., Gibson, G. & Alderman, M.H. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. American Journal of Medicine 108, 2–8.CrossRefGoogle ScholarPubMed

Cohen, H.W., Madhavan, S. & Alderman, M.N. (2001a). History of treatment for depression: risk factor for myocardial infarction in hypertensive patients. Psychosomatic Medicine 63, 203–209.CrossRefGoogle ScholarPubMed

Cohen, H.W., Madhavan, S. & Alderman, M.H. (2001b). High and low serum potassium associated with cardiovascular events in diuretictreated patients. Journal of Hypertension 19, 1315–1323.CrossRefGoogle ScholarPubMed

ENRICHD Investigators (2000). Enhancing recovery in coronary heart disease (ENRICHD): study design and methods. American Heart Journal 139(1), 1–9.CrossRefGoogle Scholar

Everson, S.A., Kaplan, G.A., Goldberg, D.E., Salonen, R. & Salonen, J.T. (1997). Hopelessness and 4-year progression of carotid atherosclerosis. Arteriosclerosis and Thrombosis 17, 1490–1495.CrossRefGoogle ScholarPubMed

Ford, D.E., Mead, L.A., Chang, P.P., Cooper-Patrick, L., Wang, N.Y. & Klag, M.J. (1998). Depression is a risk factor for coronary artery disease in men: the Precursors Study. Archives of Internal Medicine 158, 1422–1426.CrossRefGoogle ScholarPubMed

Frasure-Smith, N., Lesperance, F. & Talajic, M. (1995). Depression and 18-month prognosis after myocardial infarction. Circulation 91(4), 999–1005.CrossRefGoogle ScholarPubMed

Glassman, A.H. (1998). Depression andd the course of coronary artery disease. American Journal of Psychiatry 155, 4–11.CrossRefGoogle Scholar

Lapane, K.L., Zierler, S., Lasater, T.M., Barbour, M.M., Carleton, R. & Hume, A.L. (1995). Is the use of psychotropic drugs associated with increased risk of ischemic heart disease? Epidemiology 6(4), 376–381.CrossRefGoogle ScholarPubMed

Musselman, D.L., Tomer, A., Manatunga, A.K., Knight, B.T., Porter, M.R., Kasey, S., Marzic, U, Harker, L.A. & Nemeroff, C.G. (1996). Exaggerated platelet reactivity in major depression. American Journal of Psychiatry 153, 1313–1317.Google ScholarPubMed

Nemeroff, C.B. & Musselman, D.L. (2000). Are platelets the link between depression and ischemic heart disease? American Heart Journal 140, Suppl. 4, 57–62.CrossRefGoogle Scholar

O'Connor, C.M., Glassman, A.H., Harrison, W.M., for the SADHART Investigators (2001). A randomized double-blind placebo controlled trial of the selective serotonin reuptake inhibitor (SSRI) sertraline for major depression after acute coronary syndromes (ACS). In The SADHART Trial. American Heart Association Scientific Sessions 2001, Nov. 11, 2001 Abstract 102513, Anaheim, California.Google Scholar

Penninx, B.W., Beekman, A.T., Honig, A., Deeg, D.J., Schoevers, R.A., van Eijk, J.T. & Tilbur, van. Depression and cardiac mortality: results from a community-based longitudinal study. Archives of General Psychiatry 58(3), 229–230.Google Scholar

Pratt, L.A., Ford, D.E., Crum, R.M., Armenian, H.K., Gallo, J.J. & Eaton, W.W. (1996). Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 94, 3123–3129.CrossRefGoogle ScholarPubMed

Roose, S.P., Laghrissi-Thode, F., Kennedy, J.S. et al. , (1998). Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. Journal of the American Medical Association 279, 287–291.CrossRefGoogle ScholarPubMed

Sauer, W.H., Berlin, J.A. & Kimmel, S.E. (2001). Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104(16), 1894–1898.CrossRefGoogle ScholarPubMed

Sesso, H.D., Kawachi, I., Vokonan, P.S. & Sparrow, D. (1998). Depression and the risk of coronary heart disease in the Normative Aging Study. American Journal of Cardiology 82(7), 851–856.CrossRefGoogle ScholarPubMed

Shapiro, P.A., Lesperance, F., Frasure-Smith, N., O'Connor, C.M., Baker, B., Jiang, W., Dorian, P., Harrison, W. & Glassman, A.H. (1999). An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHART Trial). Sertraline Anti-Depression Heart Attack Trial. American Heart Journal 137, 1100–1106.CrossRefGoogle Scholar

Thomas, C, Kelman, H.R., Kennedy, G.J., Ahn, C & Yang, C (1992). Depressive symptoms and mortality in elderly persons. Journal of Gerontology 47(2), S80–S87.CrossRefGoogle ScholarPubMed

Vogt, T., Pope, C, Mullooly, J. & Hollis, J. (1994). Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. American Journal of Public Health 84, 227–231.CrossRefGoogle ScholarPubMed

Wassertheil-Smoller, S., Applegate, W.B., Berge, K., Chang, C.J., Davis, B.R., Grimm, R. Jr, Kostis, J., Pressel, S. & Schron, E. (1996). Change in depression as a precursor of cardiovascular events. Arclu'ves of Internal Medicine 156, 553–561.CrossRefGoogle ScholarPubMed